Life Science Cluster Flemingsberg – ERDF Project for growth in Life Science
Life Science Cluster Flemingsberg – ERDF Project for growth in Life Science
Flemingsberg is taking a major step toward establishing itself as a key player in Life Science with the launch of the project “Life Science Cluster Flemingsberg.” The project has been granted funding from the European Regional Development Fund and aims to boost the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.
The Stockholm region has significant potential in life science, largely thanks to strong connections between business and academia. The region acts as an essential driver of innovation and growth in Sweden’s life science sector, where SMEs play a central role. To further strengthen this position, the project aims to support the growth and establishment of SMEs in the Stockholm region’s life science sector. By creating attractive networks, improving access to research infrastructure, and promoting sustainable collaboration, the project will contribute to the long-term development of the industry.
Growth and Innovation
Running from February 2025 to 2027, the project aims to enhance growth and innovation within the Stockholm region’s life science sector. The initiatives include creating networking groups, organizing seminars and events, matching companies’ needs for research infrastructure with facilities in Flemingsberg, and collaborating with municipalities and regions on strategies that facilitate SMEs and new business establishments. Additionally, the project will establish platforms for collaboration between companies within the sustainability domain, including circularity and shared resource utilization.
Leadership and Partners
The initiative is led by the Flemingsberg Science Foundation in collaboration with co-funders Huddinge Municipality, Botkyrka Municipality, Region Stockholm, and Hemsö, along with close partners Karolinska Institutet and Region Stockholm’s Life Science Office. With a shared vision and coordinated efforts, the project aims to make Flemingsberg one of Europe’s most attractive destinations for Life Science.
In summary, the project connects the strong resources within the Stockholm region’s life science sector with concrete actions to strengthen innovation and growth. Through the planned initiatives, the project lays the foundation for Flemingsberg to become a leading international cluster. This means new opportunities for small and medium-sized enterprises, strengthening the region’s competitiveness, and helping position Sweden as a global player in life science. The result will be a sustainable and innovative environment that creates long-term benefits for businesses, research, and society.
CONTACT
Natasha Bank
Cluster Manager, Flemingsberg Science
natasha.bank@flemingsbergscience.se
+46 737 77 14 77
Angela Hoyer
Networks and Event Manager, Flemingsberg Science
angela.hoyer@flemingsbergscience.se
+46 767 71 63 03
Ellen Mäkipiha
Communications Officer, Flemingsberg Science
ellen.makipiha@flemingsbergscience.se
+46 761 17 76 37
EVENTS
NEWS
Welcome to The Park Novum!
At The Park Novum, you’re met with spacious offices, creative spaces, and a sweeping view over a growing Flemingsberg. Here, entrepreneurs, innovators, and researchers can find a home that not only provides a modern workplace, but also the opportunity to grow together.
It’s official – Alfa Laval has opened its new premises in Flemingsberg!
The new 8,000 m² innovation center brings together 700 experts who push the boundaries of future solutions in energy, food, pharma and marine transport every day. An investment that truly shows how important Swedish industrial expertise, open collaborations and continued R&D are – not only for Alfa Laval, but for the whole of Europe.
50 years of life-changing therapies
On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.
OptiCell Solutions enters a research collaboration with Karolinska Institutet
With the goal of supporting academia, healthcare, and industry in developing the cell and gene therapies of the future, OptiCell Solutions established its operations in Flemingsberg last year. The company has now entered into a research collaboration with Karolinska Institutet, marking a significant step in the desired direction.
The Park Novum inaugurated!
On November 5, the doors to The Park Novum opened – a new co-working space in Novum Research Park. The festivities came with a Halloween theme, and gathered over 150 participants who celebrated together.
Together for the medicine of the future – Karolinska ATMP Centre and ATMP Centre Uppsala strengthens collaboration in advanced therapies
A letter of intent has been signed between the Karolinska ATMP Center and the ATMP Center Uppsala to deepen collaboration in the field of advanced therapies (ATMP). The initiative was celebrated with a joint kick-off at the end of October, where hopes for new research breakthroughs and benefits for patients were in focus.
